NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
19 hedge funds and large institutions have $21.5M invested in Nexvet Biopharma plc Ordinary Shares in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$87K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$51.8K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$29K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$25K |
| 5 |
Citigroup
New York
|
+$18.1K |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$539K |
| 2 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$298K |
| 3 |
CI
Cowen Inc
New York
|
-$18.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.36K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$1.41K |
